Figure 3 (Figure003)
Clobazam Suspension
Product Images NDC 69452-116
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 69452-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Graph 1 (Graph001)
Graph 2 (Graph002)
Newcarton001
Clobazam is a medication available in an oral suspension form, primarily used for oral administration. Each bottle comes with two 10 mL oral syringes for usage. The product should be stored and dispensed in an upright position. It should be used within 90 days of the first opening, and any remainder must be discarded. The medication guide and instructions provided with each prescription should be ensured to be dispensed. It is manufactured and distributed by Bionpharma Inc.*
Figure 2 (Newfigure002)
Figure 9 (Newfigure009)
Figure 1 (Revisedfigure001v4)
This is a list of words that doesn't provide enough information to generate a description. It appears to be a random set of words without a clear context or connection.*
Figure 5 (Revisedfigure005v4)
Figure 4 (Revisedimage004v3)
Figure 6 (Revisedimage006v4)
Figure 7 (Revisedimage007v4)
Figure 8 (Revisedimage008v4)
Stucture (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
